Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a small software revision. It does not change any study information or user-facing functionality beyond metadata.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision changes from v3.6.4 to v3.6.5 are shown at the bottom of the page, signaling a platform release. The update appears to be a backend/administrative change rather than affecting study content or data.SummaryDifference0.1%

- Check50 days agoChange DetectedAdds the Contacts/Locations and Study Status sections to the version history, improving access to study contact details and the current trial status. Introduces revision v3.6.4 for version 50 on 2026-07-17 and removes the prior v3.6.3 revision on 2026-04-23.SummaryDifference0.3%

- Check72 days agoChange DetectedThe revision tag on the page updates from v3.6.2 to v3.6.3, indicating a new release version of the page. This typically reflects a minor update to the site's underlying system rather than changes to the page content.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter shows Revision: v3.6.2, replacing v3.6.0, indicating a new build of the ClinicalTrials.gov interface. The change does not modify the study history data or how the page operates.SummaryDifference0.1%

- Check93 days agoChange DetectedRecruitment status has been updated to 'no longer looking for participants,' indicating the trial is no longer actively seeking enrollees. The revision history also shows a new release labeled v3.6.0 and the prior v3.5.5 entry has been removed from the log.SummaryDifference0.2%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.